Kimi Iguchi is CFO & Treasurer at Sage Therapeutics, Inc. (SAGE). They have made 10 open-market trades across 1 company since 2014, most recently 2024-08-05.
CIK 0001304815
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $117K since 2014, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SAGE | 85,041 | $738K |
Shares reported on the most recent Form 4, priced at the 2024-08-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SAGE | SELL | 2019-03-01 | 2019-03-01 | $156.93 | $8.0M | -1.2% | -1.7% | +7.1% |
| SAGE | SELL | 2018-04-26 | 2018-04-27 | $144.26 | $3.2M | +8.6% | +3.4% | +4.0% |
| SAGE | SELL | 2018-04-23 | 2018-04-25 | $142.58 | $6.1M | +10.1% | +10.6% | +14.4% |
| SAGE | SELL | 2017-01-13 | 2017-01-13 | $53.92 | $539K | -13.6% | -5.6% | +25.3% |
| SAGE | SELL | 2016-11-17 | 2016-11-18 | $51.77 | $207K | -5.3% | -9.1% | +20.7% |
| SAGE | SELL | 2016-11-11 | 2016-11-14 | $50.59 | $76K | -4.2% | -11.3% | -1.9% |
| SAGE | SELL | 2016-09-07 | 2016-09-09 | $40.93 | $102K | +20.6% | +17.7% | +34.5% |
| SAGE | SELL | 2016-07-12 | 2016-07-14 | $49.55 | $248K | +4.3% | -13.1% | -2.1% |
| SAGE | BUY | 2015-12-31 | 2016-01-07 | $49.56 | $9K | -17.5% | -38.4% | -19.0% |
| SAGE | SELL · 10b5-1 | 2015-09-08 | 2015-09-09 | $54.84 | $165K | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-08-10 | 2015-08-11 | $67.61 | $270K | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-07-06 | 2015-07-06 | $68.00 | $272K | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-06-08 | 2015-06-08 | $80.10 | $200K | -30.6% | -2.1% | -2.1% |
| SAGE | BUY | 2014-07-23 | 2014-07-23 | $18.00 | $108K | -30.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.